Take­da shift­ing hun­dreds of R&D staffers to Boston — re­port; Shire inks he­mo­phil­ia deal; Am­gen, Ar­ray part­ner on au­toim­mune dis­eases

→ Mod­ern Health­care re­ports that Take­da has been re­lo­cat­ing hun­dreds of R&D jobs out of Chica­go and in­to its big new biotech hub in Boston/Cam­bridge. Ac­cord­ing to the re­port, Take­da has re­quired up to 600 R&D staffers in Chica­go to re­lo­cate, along with 150 in the vac­cines group. Take­da has been shred­ding its old glob­al R&D struc­ture to fa­vor a con­cen­tra­tion of forces in Boston and Japan. But the com­pa­ny, un­der CEO Christophe We­ber and R&D chief Andy Plump, have main­tained a con­sid­er­able air of se­cre­cy in how they’re up­root­ing groups in an ef­fort to re­or­ga­nize and cre­ate a far more ef­fec­tive bio­phar­ma com­pa­ny.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER